Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Biotage AB

BIOT.ST ✓ COMPLIANT ☆ Track — members

Nasdaq Stockholm · Healthcare · Advanced Medical Equipment & Technology ·

Sweden Small Cap Analyst: N/A

Last Close

$14.96

▲ +0.14%

Market Cap $1.21B · Vol 40.31K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$1.21B

Small Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

51.43

Momentum

Beta

1.09

vs Market

52W High

$21.27

0.49% below

52W Low

$8.58

0.56% above

Volume

40.31K

Avg 174.24K

P/B

3.13

Price-to-book

ROE

7.31%

Return on equity

Free Float

N/A

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Biotage AB (BIOT.ST) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BIOT.ST pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.14%

-0.14%

+58.14%

+4.60%

YTD

-10.95%

-22.72%

+32.39%

-10.11%

Financials & Valuation

TTM · Annual

Total Revenue	$185.98M
Net Income	$25.69M
Revenue Growth (YoY)	-19.79%
Gross Margin	62.69%
Operating Margin	16.88%
Net Profit Margin	13.81%
ROE	7.31%
ROA · ROIC	6.54% · 7.22%

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	6.82
P/S	6.26
P/B	3.13
P/FCF	52.79
EPS Growth	N/A
Outstanding Shares	80.05M

Technical Indicators

50-Day SMA	$14.98
200-Day SMA	$14.84
RSI (14)	51.43
Beta	1.09
52-Week High	$21.27
52-Week Low	$8.58

Volume Today	40.31K
Avg Daily Volume (30D)	174.24K
Relative Volume	0.23x
Volatility (10D)	3.46
Volatility (30D)	4.35
Free Float	N/A

Analyst Consensus

N/A

Current Price $14.96

Mean Target N/A

52W Low$8.58 52W High$21.27

Current

Target

$8.58 $21.27

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq Stockholm

FIGIBBG001S8TG84

ISINN/A

CountrySweden

Sub-IndustryMedical Diagnostic & Testing Equipment

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

SRT.DE Sartorius AG -1.14% EUZ.DE Eckert & Ziegler SE -0.44% VREX Varex Imaging Corp -0.05% REG1V.HE Revenio Group Oyj +5.89% CEVI.ST CellaVision AB +0.26%

Company Profile

Biotage AB is a Sweden-based company that develops and sells systems, consumables and services in the field of life sciences. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The Company offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins. Biotage’s offering within analytical chemistry consists of consumables with related applications to extract selected substances from various types of samples. The Company’s offering within organic chemistry includes products for pharmaceutical development based on both small molecules and peptides and its offering within industrial resins is composed of polymer-based resins and research services that lead to the development and manufacture of polymer-based materials. As of December 31, 2013, the Company operated 12 wholly owned subsidiaries worldwide.